On Monday, OS Therapies Inc (AMEX: OSTX) opened lower -8.24% from the last session, before settling in for the closing price of $1.7. Price fluctuations for OSTX have ranged from $1.12 to $7.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 79.38% over the past five years. Company’s average yearly earnings per share was noted 148.58% at the time writing. With a float of $15.80 million, this company’s outstanding shares have now reached $21.35 million.
Let’s look at the performance matrix of the company that is accounted for 4 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
OS Therapies Inc (OSTX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of OS Therapies Inc is 43.77%, while institutional ownership is 1.39%. The most recent insider transaction that took place on May 07 ’25, was worth 163,918. In this transaction 10% Owner of this company sold 82,000 shares at a rate of $2.00, taking the stock ownership to the 2,664,199 shares. Before that another transaction happened on May 07 ’25, when Company’s 10% Owner proposed sale 1,200,000 for $2.34, making the entire transaction worth $2,808,000.
OS Therapies Inc (OSTX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.84 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 148.58% per share during the next fiscal year.
OS Therapies Inc (AMEX: OSTX) Trading Performance Indicators
Check out the current performance indicators for OS Therapies Inc (OSTX). In the past quarter, the stock posted a quick ratio of 1.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.63, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of OS Therapies Inc (OSTX)
OS Therapies Inc (AMEX: OSTX) saw its 5-day average volume 0.46 million, a negative change from its year-to-date volume of 0.78 million. As of the previous 9 days, the stock’s Stochastic %D was 20.33%.
During the past 100 days, OS Therapies Inc’s (OSTX) raw stochastic average was set at 32.12%, which indicates a significant increase from 5.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1418 in the past 14 days, which was lower than the 0.1725 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7668, while its 200-day Moving Average is $2.3157. Nevertheless, the first resistance level for the watch stands at $1.6633 in the near term. At $1.7667, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.8333. If the price goes on to break the first support level at $1.4933, it is likely to go to the next support level at $1.4267. The third support level lies at $1.3233 if the price breaches the second support level.
OS Therapies Inc (AMEX: OSTX) Key Stats
There are currently 28,098K shares outstanding in the company with a market cap of 43.84 million. Presently, the company’s annual sales total 0 K according to its annual income of -8,880 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -3,880 K.
